These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17292608)

  • 21. Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS.
    Thevis M; Kohler M; Thomas A; Maurer J; Schlörer N; Kamber M; Schänzer W
    Anal Bioanal Chem; 2008 May; 391(1):251-61. PubMed ID: 18270691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.
    Gong Y; Barbay JK; Buntinx M; Li J; Wauwe JV; Claes C; Lommen GV; Hornby PJ; He W
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3852-5. PubMed ID: 18595693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.
    Malm J; Gordon S; Brandt P; Carlsson B; Agback P; Bäckbro Saeidi A; Sandberg J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2018-21. PubMed ID: 17254783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Arylpyrimidines: novel CRF-1 receptor antagonists.
    Yoon T; De Lombaert S; Brodbeck R; Gulianello M; Krause JE; Hutchison A; Horvath RF; Ge P; Kehne J; Hoffman D; Chandrasekhar J; Doller D; Hodgetts KJ
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4486-90. PubMed ID: 18672365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold.
    Sun C; Robl JA; Wang TC; Huang Y; Kuhns JE; Lupisella JA; Beehler BC; Golla R; Sleph PG; Seethala R; Fura A; Krystek SR; An Y; Malley MF; Sack JS; Salvati ME; Grover GJ; Ostrowski J; Hamann LG
    J Med Chem; 2006 Dec; 49(26):7596-9. PubMed ID: 17181141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
    Jin J; Wang Y; Shi D; Wang F; Fu W; Davis RS; Jin Q; Foley JJ; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Busch-Petersen J
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5481-6. PubMed ID: 18818072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands.
    Van Dort ME; Jung YW
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1045-7. PubMed ID: 11327585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical basis for differences in metabolism-dependent genotoxicity by two diazinylpiperazine-based 5-HT2C receptor agonists.
    Kalgutkar AS; Bauman JN; McClure KF; Aubrecht J; Cortina SR; Paralkar J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1559-63. PubMed ID: 19246199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
    Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
    Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
    Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of piperidine carboxamide TRPV1 antagonists.
    Cheung WS; Calvo RR; Tounge BA; Zhang SP; Stone DR; Brandt MR; Hutchinson T; Flores CM; Player MR
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4569-72. PubMed ID: 18662879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists.
    Madsen-Duggan CB; Debenham JS; Walsh TF; Toupence RB; Huang SX; Wang J; Tong X; Lao J; Fong TM; Schaeffer MT; Xiao JC; Huang CR; Shen CP; Stribling DS; Shearman LP; Strack AM; MacIntyre DE; Van der Ploeg LH; Goulet MT
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2031-5. PubMed ID: 17270441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach.
    Ueda S; Kato M; Inuki S; Ohno H; Evans B; Wang ZX; Peiper SC; Izumi K; Kodama E; Matsuoka M; Nagasawa H; Oishi S; Fujii N
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4124-9. PubMed ID: 18539453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists.
    Salvati ME; Balog A; Shan W; Wei DD; Pickering D; Attar RM; Geng J; Rizzo CA; Gottardis MM; Weinmann R; Krystek SR; Sack J; An Y; Kish K
    Bioorg Med Chem Lett; 2005 Jan; 15(2):271-6. PubMed ID: 15603938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. beta-Alkylthio indolyl carbinols: potent nonsteroidal antiandrogens with oral efficacy in a prostate cancer model.
    Lanter JC; Fiordeliso JJ; Alford VC; Zhang X; Wells KM; Russell RK; Allan GF; Lai MT; Linton O; Lundeen S; Sui Z
    Bioorg Med Chem Lett; 2007 May; 17(9):2545-8. PubMed ID: 17337185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel H3 receptor antagonists with improved pharmacokinetic profiles.
    Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Semple G; Ren A; Pereira G; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Lorea J; Grottick AJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4133-6. PubMed ID: 18554904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonists.
    Paliwal S; Reichard GA; Shah S; Wrobleski ML; Wang C; Stengone C; Tsui HC; Xiao D; Duffy RA; Lachowicz JE; Nomeir AA; Varty GB; Shih NY
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4168-71. PubMed ID: 18547807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of small molecule agonists of the motilin receptor.
    Heightman TD; Conway E; Corbett DF; Macdonald GJ; Stemp G; Westaway SM; Celestini P; Gagliardi S; Riccaboni M; Ronzoni S; Vaidya K; Butler S; McKay F; Muir A; Powney B; Winborn K; Wise A; Jarvie EM; Sanger GJ
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6423-8. PubMed ID: 18980843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
    Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
    Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.